1. Home
  2. FDBC vs NTHI Comparison

FDBC vs NTHI Comparison

Compare FDBC & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fidelity D & D Bancorp Inc.

FDBC

Fidelity D & D Bancorp Inc.

N/A

Current Price

$45.97

Market Cap

255.2M

Sector

Finance

ML Signal

N/A

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$8.63

Market Cap

243.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FDBC
NTHI
Founded
1902
2008
Country
US
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.2M
243.9M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
FDBC
NTHI
Price
$45.97
$8.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.9K
61.0K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
3.81%
N/A
EPS Growth
12.85
N/A
EPS
3.50
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.00
$3.20
52 Week High
$50.00
$16.00

Technical Indicators

Market Signals
Indicator
FDBC
NTHI
Relative Strength Index (RSI) 49.27 44.47
Support Level $44.69 $9.05
Resistance Level $46.70 $11.38
Average True Range (ATR) 1.48 1.17
MACD -0.08 -0.06
Stochastic Oscillator 52.47 7.26

Price Performance

Historical Comparison
FDBC
NTHI

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: